Industry
Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer
New next generation sequencing test panels have been developed to provide more affordable advanced NGS testing that can help doctors choose the most effective cancer treatments based on tumor type and an individual’s genetic profile, an important step towards making personalized medicine broadly accessible. First launch is of a NGS colon cancer test panel. More...24 May 2015
Main Factors Driving Revenue Growth in Clinical Chemistry Identified
According to a report by Kalorama Information, the overall growth in the clinical chemistry market will be modest, driven mainly by new tests and demographic changes, including an aging population and increasing number of people at risk of cardiovascular disease, such as those with hypertension, diabetes mellitus, and abdominal obesity. More...04 May 2015
Bio-Rad Grants Beckman Coulter Exclusive Distribution for Two Infectious Disease Tests
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, and clinical diagnostics leader Beckman Coulter Diagnostics, have announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad’s Access HIV combo assay and Access Hepatitis C virus assay in select geographies. The products are currently not available in the US or Vietnam. More...27 Apr 2015
Partnership to Offer New Coagulation Testing Solutions Worldwide
Abbott and Sekisui Diagnostics, a sister company of Sekisui Medical, have entered an agreement to offer new coagulation testing solutions for clinical labs to help better assess patient risk of excessive bleeding, developing clots, and other conditions. More...26 Apr 2015
Clinical Lab Automation Sector at USD 5.4 Billion and Growing
Lab automation systems sold to clinical laboratories reached USD 5.4 billion in sales in 2014. Shortage of personnel will further drive these purchases, as will a need for new systems, according to a new market research report on the status of lab automation in both clinical and drug-discovery lab segments. More...20 Apr 2015
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gold Member
Hybrid Pipette
SWITCH
In Other News
Beyond Brazil, Latin American IVD Sector Grows
Improved Ebola IVD Tests Continue to Face Challenges
NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer
Microbiologics and Microbix Partner on Viral Controls for Diagnostics
Precision Makes dPCR a Steadily Growing Sector
Philips Collaborates with Janssen on Handheld Test for Neuropsychiatric Disorders
Latin America’s IVD Sector Exceeds USD 2 Billion, Brazil leads
“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery
Sequencing-Based Testing Sector Already Highly Competitive
US Government Funding Initiative Includes Spotlight on Tissue Diagnostics
Lab-on-Paper Developed for Rapid Inexpensive Medical Diagnostics
Partnership Expands to Advance Novel Dual-Detection of Two Neglected Tropical Diseases
Healthcare Revolution Predicted with Rise of Genomic Testing for Personalized Medicine
Blood-Based Molecular Test Improves Early Detection of Colorectal Cancer
Social Network for Diagnostics Launched
Artel Expands Portfolio with STRATEC Partnership for Automation Technology
After First Approval of a Rapid Molecular Test, Expect More
Collaboration Agreement Targets Tumor-Related Genes
Emerging Products Provide Opportunity in Prenatal Diagnostics
Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients
Report Predicts Double-Digit Growth for Protein Microarrays
Aperiomics Presents Innovative Diagnostics Technology
WEF Selects Transasia Bio-Medicals for Global Growth Company Award
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.